CGA restrains the apoptosis of Aβ_25-35-induced hippocampal neurons

References

• Hogh P. Alzheimer's disease. Ugeskrift for laeger. 2017;179(12):V09160686.
   Google Scholar
• Lane CA, Hardy J, Schott JM. Alzheimer's disease. Eur J Neurol. 2018;25(1):59–70.
   PubMed Web of Science ®Google Scholar
• Lee M, Guo JP, Kennedy K, et al. A method for diagnosing Alzheimer's disease based on salivary amyloid-beta protein 42 levels. JAD.. 2016;55(3):1175–1182.
   Web of Science ®Google Scholar
• O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011;34:185–204.
   PubMed Web of Science ®Google Scholar
• Roher AE, Kokjohn TA, Clarke SG, et al. APP/Abeta structural diversity and Alzheimer's disease pathogenesis. Neurochem Int. 2017;110:1–13.
   PubMed Web of Science ®Google Scholar
• Takahashi RH, Nagao T, Gouras GK. Plaque formation and the intraneuronal accumulation of beta-amyloid in Alzheimer's disease. Pathol Int. 2017;Apr67(4):185–193.
   PubMed Web of Science ®Google Scholar
• Li L, Xu S, Liu L, et al. Multifunctional compound AD-35 improves cognitive impairment and attenuates the production of TNF-alpha and IL-1beta in an abeta25-35-induced rat model of Alzheimer's disease. JAD. 2017;56(4):1403–1417.
   Web of Science ®Google Scholar
• Xie JW, Zhao Y, Feng XL, et al. Protective effect of butylphthalide in a cell model of Alzheimer's disease induced by Abeta25-35 in Neuro 2a cells. Nan fang yi ke da xue xue bao J South Med Univ. 2017; 37(9):1228–1233.
   PubMedGoogle Scholar
• Weir HJ, Murray TK, Kehoe PG, et al. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PloS one. 2012;7(11):e48225.
   PubMed Web of Science ®Google Scholar
• Laroche ML, Perault-Pochat MC, Ingrand I, et al. Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study. Pharmacoepidemiol Drug Saf.. 2013;22(9):952–960.
   PubMed Web of Science ®Google Scholar
• Pazzagli L, Benedetti E, Agostino E, et al. Antipsycothic drugs in dementia and Alzheimer's disease: pharmacovigilance plan in Florence. Eur J Hosp Pharm. 2012;19(2):112–112.
   Google Scholar
• Klimova B, Kuca K. Alzheimer's disease and Chinese medicine as a useful alternative intervention tool: a mini-review. CAR. 2017;14(6):680–685.
   Web of Science ®Google Scholar
• Naveed M, Hejazi V, Abbas M, et al. Chlorogenic acid (CGA): a pharmacological review and call for further research. Biomed Pharmacother. 2018;97:67–74.
   PubMed Web of Science ®Google Scholar
• Liang N, Kitts DD. Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients. 2015;8(1):16.
   PubMed Web of Science ®Google Scholar
• Camfield DA, Silber BY, Scholey AB, et al. A randomised placebo-controlled trial to differentiate the acute cognitive and mood effects of chlorogenic acid from decaffeinated coffee. PloS one. 2013;8(12):e82897.
   PubMed Web of Science ®Google Scholar
• Pathak L, Agrawal Y, Dhir A. Natural polyphenols in the management of major depression. Expert Opin Invest Drugs. 2013;22(7):863–880.
   PubMed Web of Science ®Google Scholar
• Amarowicz R, Pegg RB. The potential protective effects of phenolic compounds against low-density lipoprotein oxidation. CPD. 2017;23(19):2754–2766.
   Web of Science ®Google Scholar
• Liang Y, Huang M, Jiang X, et al. The neuroprotective effects of Berberine against amyloid beta-protein-induced apoptosis in primary cultured hippocampal neurons via mitochondria-related caspase pathway. Neurosci Lett. 2017;655:46–53.
   PubMed Web of Science ®Google Scholar
• Masters CL, Bateman R, Blennow K, et al. Alzheimer's disease. Nat Rev Dis Primers. 2015;1(1):15056.
   PubMed Web of Science ®Google Scholar
• Mucke L, Selkoe DJ. Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harbor Perspect Med. 2012;2(7):a006338.
   PubMed Web of Science ®Google Scholar
• Kozlov S, Afonin A, Evsyukov I, et al. Alzheimer's disease: as it was in the beginning. Rev Neurosci. 2017;28(8):825–843.
   PubMed Web of Science ®Google Scholar
• Al-Amin MM, Akhter S, Hasan AT, et al. The antioxidant effect of astaxanthin is higher in young mice than aged: a region specific study on brain. Metab Brain Dis. 2015;30(5):1237–1246.
   PubMed Web of Science ®Google Scholar
• Wang P, Wu Q, Wu W, et al. Mitochondrial ferritin deletion exacerbates beta-amyloid-induced neurotoxicity in mice. Oxid Med Cell Longevity. 2017;2017:1.
   Web of Science ®Google Scholar
• Cheng Y, Leng W, Zhang J. Protective effect of puerarin against oxidative stress injury of neural cells and related mechanisms. Med Sci Monit. 2016;22:1244–1249.
   PubMed Web of Science ®Google Scholar
• Gul Z, Demircan C, Bagdas D, et al. Protective effects of chlorogenic acid and its metabolites on hydrogen peroxide-induced alterations in rat brain slices: a comparative study with resveratrol. Neurochem Res. 2016;41(8):2075–2085.
   PubMed Web of Science ®Google Scholar
• Shi H, Shi A, Dong L, et al. Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress. Clin Nutr. 2016;35(6):1366–1373.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Koppel S, Weidling I, et al. Mitochondria, cybrids, aging, and Alzheimer's disease. Prog Mol Biol Transl Sci. 2017;146:259–302.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer's disease. JAD. 2018;62(3):1403–1416.
   Web of Science ®Google Scholar
• Obulesu M, Lakshmi MJ. Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues. Neurochem Res. 2014;39(12):2301–2312.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cai B, Shao J, et al. Genistein suppresses the mitochondrial apoptotic pathway in hippocampal neurons in rats with Alzheimer's disease. Neural Regen Res. 2016;11(7):1153–1158.
   PubMed Web of Science ®Google Scholar
• Santos LE, Ferreira ST. Crosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer's disease. Neuropharmacology. 2018;136:350–360.
   PubMed Web of Science ®Google Scholar
• Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016;73(1):79–94.
   PubMed Web of Science ®Google Scholar
• Li JQ, Yu JT, Jiang T, et al. Endoplasmic reticulum dysfunction in Alzheimer's disease. Mol Neurobiol. 2015;51(1):383–395.
   PubMed Web of Science ®Google Scholar
• Rozpedek W, Pytel D, Mucha B, et al. The role of the PERK/eIF2alpha/ATF4/CHOP Signaling pathway in tumor progression during endoplasmic reticulum stress. CMM. 2016;16(6):533–544.
   PubMed Web of Science ®Google Scholar
• Wang YC, Dong J, Nie J, et al. Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition. Apoptosis Int J Programmed cell death. 2017;22(9):1147–1156.
   PubMed Web of Science ®Google Scholar
• Shan S, Tian L, Fang R. Chlorogenic acid exerts beneficial effects in 6-hydroxydopamine-induced neurotoxicity by inhibition of endoplasmic reticulum stress. Med Sci Monit. 2019;25:453–459.
   PubMed Web of Science ®Google Scholar